Predictive Health Diagnostics has developed the PULS test, which cost effectively helps in the fight against cardiovascular and other preventable diseases with the use of molecular diagnostic technologies. Developed by Dr. Douglas Harrington and independently validated through clinical trials at the National Institute of Health, the PULS test very accurately detects and measures the level of coronary heart disease present in the human body as well as assesses the likelihood of a patient experiencing a heart attack over the ensuing five years. Since 2015, the Company’s laboratory subsidiary, Global Diagnostic Biosciences (“GDB”) has completed over 10,000 PULS tests.
http://gdbiosciences.com/meet-our-ceo
Location: United States, California, Irvine
Employees: 11-50